Paratek Pharmaceuticals (NASDAQ:PRTK) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Paratek Pharmaceuticals their estimated earnings by 17.78%, reporting an EPS of $-0.37 versus an estimate of $-0.45, which surprised analysts.
Revenue was up $10,788,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11, which was followed by a 4.14% drop in the share price the next day.
Here’s a look at Paratek Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.31 | -0.38 | -0.04 | -0.61 |
| EPS Actual | 0.20 | -0.39 | -0.49 | -0.46 |
| Revenue Estimate | 60.99M | 28.72M | 34.04M | 11.90M |
| Revenue Actual | 57.49M | 16.43M | 16.02M | 13.66M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
